University of Washington ACTU Seeks Participants for Two New Studies

University of Washington
AIDS Clinical Trials Unit
325 9th Avenue, Second Floor (2West Clinic)
Seattle, WA 98104
206.731.3184
actu@u.washington.edu
http://depts.washington.edu/actu

Latest HIV/AIDS Clinical Trials

Neuropathy Study

Open-label, Dose-escalation, Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy Pilot Study

Purpose: to see if taking acetyl-L-carnitine (ALC), an investigational substance, reduces neuropathy (numbness, pain, or tingling in legs and feet) in people who are taking anti-HIV drugs ddC, or ddI or d4T.

Length: 24 weeks

Reimbursement: exams, acetyl-L-carnitine, and lab tests given at no cost. Reimbursement of $20 per visit plus $50 for each visit when skin biopsies are done.

Contact: Alyssa Spingola or Lori Cray at (206) 731-3184 (spingola@u.washington.edu)

Semen Study

Crossover trial of valganciclovir in persons with HIV-1 infection and HIV and CMV co-shedding in semen

Purpose: to evaluate the effectiveness of oral valganciclovir in decreasing the shedding of HIV in semen.

Length: 12 weeks after entry

Reimbursement: Semen samples are reimbursed at the following rates: $15 for screening samples, $25 for each of the three samples at weeks 2-4, and $40 for each of the samples at weeks 8, 10, 11, and 12.

Contact: Leslie Deutsch (206) 543-8299 (leslie@u.washington.edu)